TriangleFOR PATIENTS · SOURCE READING
Key Points
Source: Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset Patient source covers mycosis fungoides/Sezary syndrome; do not apply to all other cutaneous T-cell lymphomas.
Context: Treatment Option Overview
There are different types of treatment for patients with mycosis fungoides and cancer.
Seven types of standard treatment are used:
Seven types of standard treatment are used:
Photodynamic therapy
Seven types of standard treatment are used:
Radiation therapy
Seven types of standard treatment are used:
Chemotherapy
Seven types of standard treatment are used:
Other drug therapy
Seven types of standard treatment are used:
Immunotherapy
Seven types of standard treatment are used:
Targeted therapy
Seven types of standard treatment are used:
High-dose chemotherapy and radiation therapy with stem cell transplant
New types of treatment are being tested in clinical trials.
New types of treatment are being tested in clinical trials.
Immune checkpoint inhibitor therapy
Treatment for mycosis fungoides and Sézary syndrome may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Preserved source evidence · Independent clinical review pending · Not medical advice